Report to 30 June 1999

MORGAN GRENFELL EQUITY INCOME TRUST PLC 9 July 1999 REPORT TO 30 JUNE 1999 MARKET BACKGROUND The UK equity market, as measured by the FTSE All-Share Index, rose by just 1.8% in capital terms in the three months to 30 June. This was despite continued evidence of reasonable growth in the economy and two further 0.25% reductions in interest rates. The constraint on the market was the uncertainty over the direction of US interest rate policy, together with some signs of a pick-up in commodity prices. Small and medium sized companies outperformed the market by 9.5% and 5.8% respectively, driven by a recovery in the share prices of companies more sensitive to the rate of economic growth. As a result, industrial sectors such as Resources, Steel, Chemicals, Automobiles and Packaging all performed well. The portfolio benefited from this and our diluted net asset value rose 8.4% outperforming the FTSE All-Shares Index by 6.6%, thereby adding to the outperformance achieved in the six months to 31 March. Activity over the period contained a mixture of growth and income ideas. We bought some situations where we felt that the downside was limited and change will realise value, good examples being Unigate, Rank and Tomkins. On the growth track we purchased AstraZeneca after a period of sharp underperformance and established a holding in Euromoney Institutional Investor, a little followed yet attractive media company. On the sale side we began to reduce the holding in Lonmin (formerly Lonrho) which has been a successful resource investment. We also took advantage of the strong move in some of the cyclical shares to reduce or sell out, good examples being Barratt Developments, Williams, Arjo Wiggins and Premier Farnell. Our overall strategy is unaltered from that described in the recent interim report, namely we continue to see a low inflation environment with only very modest growth and this leads us to be cautious of pursuing companies that are reliant on a strong resurgence in inflation and growth. NET ASSET VALUE Fully diluted 30/06/99 31/03/99 30/06/99 31/03/99 256.4p 236.7p 249.8p 230.9p MID-MARKET SHARE PRICE 30/06/99 31/03/99 Ordinary Shares 211.0p 210.75p Warrants 105.50p 99.50p LARGEST HOLDINGS (market value £59.3 million equal to 60.5% of total portfolio) % of 30/06/99 £'000's portfolio BP Amoco 6,159 6.3 HSBC Holdings 4,334 4.4 British Telecom 4,034 4.1 Glaxo Wellcome 3,453 3.5 AstraZeneca 3,024 3.1 Cookson Group 2,800 2.9 Shell Transport & Trading 2,664 2.7 Royal & Sun Alliance 2,429 2.5 Vodafone Airtouch 2,314 2.4 Cable & Wireless 2,271 2.3 General Electric 2,199 2.2 British American Tobacco 2,092 2.1 SmithKline Beecham 2,030 2.1 Barclays 1,913 2.0 BPB 1,880 1.9 Billiton 1,840 1.9 United Utilities 1,725 1.8 National Westminster 1,679 1.7 Carlton Communications 1,673 1.7 Diageo 1,562 1.6 Unigate 1,501 1.5 Bass 1,457 1.5 Express Dairies 1,440 1.5 British Aerospace 1,412 1.4 Countrywide Assured 1,404 1.4 For further information, contact Adrian Frost at Morgan Grenfell on 0171-545-6000. For additional copies, changes of address or details of our Private Investors' Plan contact Mark Pope on 0171-545-0520, e-mail address: mark.pope@db.com Issued by Morgan Grenfell Equity Income Trust PLC and approved by Morgan Grenfell Trust Managers Limited, regulated by the Investment Management Regulatory Organisation and manager of Morgan Grenfell Equity Income Trust PLC. Investors should be aware that past performance is not necessarily a guide to future returns, values can fall as well as rise and investors may not get back the amount they invested.
UK 100

Latest directors dealings